Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001415889-24-019829

Chief Medical Officer sold 1,500 shares at $35.00 ($52,500)

  • Chief Medical Officer acquired 1,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lizzul Paul F. Chief Medical Officer 2024-07-18 Option exercise 10b5-1 +1,500 $18.50 $27,750 13,118 D: show line 1 in the form
Lizzul Paul F. Chief Medical Officer 2024-07-18 Sale 10b5-1 −1,500 $35.00 $52,500 11,618 D: show line 2 in the form
Open-market sales · 1,500 sh · avg $35.00 · $52,500

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lizzul Paul F. Chief Medical Officer 2024-07-18 Option exercise · Common 10b5-1 −1,500 88,500 D: show line 3 in the form
Loading xslF345X05/form4-07202024_120740.xml…